PGPatricia Guerry

Patricia Guerry

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Patricia Guerry has a total of 92 co-authors. Here are the top co-authors by number of shared publications:

  • Cheryl P. Ewing

    Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, USA

    9 shared publications
  • Thomas E. Hickey

    Enteric Diseases Department, Naval Medical Research Center, Silver Spring, Maryland 20910

    6 shared publications
  • Gary Majam

    Enteric Diseases Department, Naval Medical Research Center, Silver Spring, Maryland 20910

    4 shared publications
  • Anthony P. Moran

    Department of Natural Sciences, Fayetteville State University, Fayetteville, North Carolina,1 Enteric Diseases Department, Naval Medical Research Center, Silver Spring, Maryland and,2 Department of Microbiology, National University of Ireland, Galway, Ireland3

    3 shared publications
  • Maria Lorenzo

    Enteric Diseases,1 Biological Defense Research Directorates, Naval Medical Research Center, Silver Spring, Maryland,2 Food and Drug Administration, Beltsville, Maryland3

    3 shared publications
  • Scarlett Goon

    Enteric Diseases Department, Naval Medical Research Center, Silver Spring, Maryland 20910

    3 shared publications

Latest Publications

  • Campylobacter jejuni transcriptional and genetic adaptation during human infection

    by Alexander A. Crofts, Frédéric M. Poly, Cheryl P. Ewing, Janelle M. Kuroiwa, Joanna E. Rimmer, Clayton Harro, David Sack, Kawsar R. Talaat, Chad K. Porter, Ramiro L. Gutierrez, et al.

    Campylobacter jejuni infections are a leading cause of bacterial food-borne diarrhoeal illness worldwide, and Campylobacter infections in children are associated with stunted growth and therefore long-term deficits into adulthood. Despite this global impact on health and human capital, how zoonotic C. jejuni responds to the human host remains unclear. Unlike other intestinal pathogens, C. jejuni does not harbour pathogen-defining toxins that explicitly contribute to disease in humans. This makes understanding Campylobacter pathogenesis challenging and supports a broad examination of bacterial factors that contribute to C. jejuni infection. Here, we use a controlled human infection model to characterize C. jejuni transcriptional and genetic adaptations in vivo, along with a non-human primate infection model to validate our approach. We found that variation in 11 genes is associated with either acute or persistent human infections and includes products involved in host cell invasion, bile sensing and flagella modification, plus additional potential therapeutic targets. In particular, a functional version of the cell invasion protein A (cipA) gene product is strongly associated with persistently infecting bacteria and we identified its biochemical role in flagella modification. These data characterize the adaptive C. jejuni response to primate infections and suggest therapy design should consider the intrinsic differences between acute and persistently infecting bacteria. In addition, RNA sequencing revealed conserved responses during natural host commensalism and human infections. Thirty-nine genes were differentially regulated in vivo across hosts, lifestyles and C. jejuni strains. This conserved in vivo response highlights important C. jejuni survival mechanisms such as iron acquisition and evasion of the host mucosal immune response. These advances highlight pathogen adaptability across host species and demonstrate the utility of multidisciplinary collaborations in future clinical trials to study pathogens in vivo.


  • Epidemiology of Campylobacter Infections among Children in Egypt

    by Rebecca Sainato, Atef ElGendy, Frédéric Poly, Janelle Kuroiwa, Patricia Guerry, Mark S. Riddle, Chad K. Porter

    Campylobacter is a frequently isolated bacterial pathogen among children with diarrhea. Data are lacking on the distribution and spectrum of disease associated with Campylobacter species and Campylobacter jejuni capsular polysaccharide (CPS) types. This information is essential because current vaccine research seeks to target specific CPS types. An effective CPS-conjugate vaccine will need to cover CPS types that are both common and associated with severe disease. The US Naval Medical Research Unit-3 conducted several prospective cohort studies researching diarrheal disease in Egypt from 1995 to 2003. In total, 1,057 children were enrolled and followed to a maximum age of 36 months. We analyzed Campylobacter-positive stool samples that were collected while subjects were symptomatic, along with corresponding clinical data. Of 441 Campylobacter isolates, 322 represented primary infections (189 C. jejuni, 127 Campylobacter coli, six unspeciated). There were 19 C. jejuni CPS types identified; eight accounted for 63.5% of primary C. jejuni infections. We also screened for the presence of the type-6 secretion system (T6SS), a putative virulence determinant. The T6SS was found in 18.0% of C. coli isolates and 57.6% of C. jejuni isolates (P < 0.001), and was not uniformly distributed among CPS types (P < 0.001). Strains with the T6SS were not associated with more severe disease. Clinical presentations across species and CPS types appeared similar. This study adds to the growing epidemiological data and also provides some analysis of the clinical spectrum associated with infection by specific Campylobacter species, C. jejuni capsule types, and possible virulence determinants.


  • Phase-Variable Changes in the Position ofO-Methyl Phosphoramidate Modifications on the Polysaccharide Capsule of Campylobacter jejuni Modulate Serum Resistance

    by Brittany Pequegnat, Renee M. Laird, Cheryl P. Ewing, Christina L. Hill, Eman Omari, Frederic Poly, Mario A. Monteiro, Patricia Guerry

    Campylobacter jejunipolysaccharide capsules (CPS) are characterized by the presence of nonstoichiometricO-methyl phosphoramidate (MeOPN) modifications. The lack of stoichiometry is due to phase variation at homopolymeric tracts within the MeOPN transferase genes.C. jejunistrain 81-176 contains two MeOPN transferase genes and has been shown previously to contain MeOPN modifications at the 2 and 6 positions of the galactose (Gal) moiety in the CPS. We demonstrate here that one of the two MeOPN transferases, encoded by CJJ81176_1435, is bifunctional and is responsible for the addition of MeOPN to both the 2 and the 6 positions of Gal. A new MeOPN at the 4 position of Gal was observed in a mutant lacking the CJJ81176_1435 transferase and this was encoded by the CJJ81176_1420 transferase. During routine growth of 81-176, the CJJ81176_1420 transferase was predominantly in an off configuration, while the CJJ81176_1435 transferase was primarily on. However, exposure to normal human serum selected for cells expressing the CJJ81176_1420 transferase. MeOPN modifications appear to block binding of naturally occurring antibodies to the 81-176 CPS. The absence of MeOPN-4-Gal resulted in enhanced sensitivity to serum killing, whereas the loss of MeOPN-2-Gal and MeOPN-6-Gal resulted in enhanced resistance to serum killing, perhaps by allowing more MeOPN to be put onto the 4 position of Gal.IMPORTANCECampylobacter jejuniundergoes phase variation in genes encoding surface antigens, leading to the concept that a strain of this organism consists of multiple genotypes that are selected for fitness in various environments. Methyl phosphoramidate modifications on the capsule ofC. jejuniblock access of preexisting antibodies in normal human sera to the polysaccharide chain, thus preventing activation of the classical arm of the complement cascade. We show that the capsule of strain 81-176 contains more sites of MeOPN modifications than previously recognized and that one site, on the 4 position of galactose, is more critical to complement resistance than the others. Exposure to normal human serum selects for variants in the population expressing this MeOPN modification.


  • Distribution of Campylobacter jejuni capsular types, 2007–2012, Philadelphia, PA

    by Charles Garrigan, Abora Ettela, Frédéric Poly, Patricia Guerry, Irving Nachamkin


  • Divergence of Quaternary Structures Among Bacterial Flagellar Filaments

    by Vitold E. Galkin, Xiong Yu, Jakub Bielnicki, John Heuser, Cheryl P. Ewing, Patricia Guerry, Edward H. Egelman

    It has been widely assumed that the atomic structure of the flagellar filament from Salmonella typhimurium serves as a model for all bacterial flagellar filaments given the sequence conservation in the coiled-coil regions responsible for polymerization. On the basis of electron microscopic images, we show that the flagellar filaments from Campylobacter jejuni have seven protofilaments rather than the 11 in S. typhimurium . The vertebrate Toll-like receptor 5 (TLR5) recognizes a region of bacterial flagellin that is involved in subunit-subunit assembly in Salmonella and many other pathogenic bacteria, and this short region has diverged in Campylobacter and related bacteria, such as Helicobacter pylori , which are not recognized by TLR5. The driving force in the change of quaternary structure between Salmonella and Campylobacter may have been the evasion of TLR5.


  • Open Access

    Genome Sequence of a Clinical Isolate of Campylobacter jejuni from Thailand

    by FrédÉrIc Poly, Timothy Read, David R. Tribble, Shahida Baqar, Maria Lorenzo, Patricia Guerry

  • Open Access

    Heterogeneity of a Campylobacter jejuni Protein That Is Secreted through the Flagellar Filament

    by Frédéric Poly, Cheryl Ewing, Scarlett Goon, Thomas E. Hickey, David Rockabrand, Gary Majam, Lanfong Lee, Julie Phan, Nicholas J. Savarino, Patricia Guerry

    Cj0859c, or FspA, is a small, acidic protein of Campylobacter jejuni that is expressed by a σ 28 promoter. Analysis of the fspA gene in 41 isolates of C. jejuni revealed two overall variants of the predicted protein, FspA1 and FspA2. Secretion of FspA occurs in broth-grown bacteria and requires a minimum flagellar structure. The addition of recombinant FspA2, but not FspA1, to INT407 cells in vitro resulted in a rapid induction of apoptosis. These data define a novel C. jejuni virulence factor, and the observed heterogeneity among fspA alleles suggests alternate virulence potential among different strains.


  • Genome Sequence of a Clinical Isolate of Campylobacter jejuni from Thailand

    by Frédéric Poly, Timothy Read, David R. Tribble, Shahida Baqar, Maria Lorenzo, Patricia Guerry

    Campylobacter jejuni CG8486, which belongs to the HS4 complex, was isolated from a patient with inflammatory diarrhea in Thailand. This strain caused a diarrheal disease in ferrets comparable to that caused by C. jejuni strain 81-176, but it was much less invasive for epithelial cells in vitro than 81-176. Complete genome sequencing of CG8486 revealed a 1.65-Mb genome that was very similar to the other two published genomes of clinical isolates of C. jejuni , the genomes of 81-176 and NCTC 11168, with a limited number of CG8486-specific genes mapping outside the hypervariable carbohydrate biosynthesis loci. These data suggest that the genes required for induction of inflammatory diarrhea are among the genes shared by CG8486 and 81-176 but that either major changes in the carbohydrate loci and/or more subtle changes in other genes may modulate virulence.


  • Mutation ofwaaC, Encoding Heptosyltransferase I inCampylobacter jejuni81-176, Affects the Structure of both Lipooligosaccharide and Capsular Carbohydrate

    by Margaret I. Kanipes, Erzsebet Papp-Szabo, Patricia Guerry, Mario A. Monteiro

    Campylobacter jejuni81-176 lipooligosaccharide (LOS) is composed of two covalently linked domains: lipid A, a hydrophobic anchor, and a nonrepeating core oligosaccharide, consisting of an inner and outer core region. We report the isolation and characterization of the deepest roughC. jejuni81-176 mutant by insertional mutagenesis into thewaaCgene, encoding heptosyltransferase I that catalyzes the transfer of the firstl-glycero-d-manno-heptose residue to 3-deoxy-d-manno-octulosonic residue (Kdo)-lipid A. Tricine gel electrophoresis, followed by silver staining, showed that site-specific mutation in thewaaCgene resulted in the expression of a severely truncated LOS compared to wild-type strain 81-176. Gas-liquid chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy showed that thewaaCLOS species lacked all sugars distal to Kdo-lipid A. Parallel structural studies of the capsular polysaccharides of the wild-type strain 81-176 andwaaCmutant revealed loss of the 3-O-methyl group in thewaaCmutant. Complementation of theC. jejunimutant by insertion of the wild-typeC. jejuni waaCgene into a chromosomal locus resulted in LOS and capsular structures identical to those expressed in the parent strain. We also report here the presence ofO-methyl phosphoramidate in wild-type strain 81-176 capsular polysaccharide.


  • Open Access

    Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence

    by Patricia Guerry, Cheryl P. Ewing, Michael Schirm, Maria Lorenzo, John Kelly, Dawn Pattarini, Gary Majam, Pierre Thibault, Susan Logan

    Summary: Analysis of the complete flagellin glycosylation locus of Campylobacter jejuni strain 81–176 revealed a less complex genomic organization than the corresponding region in the genome strain, C. jejuni NCTC 11168. Twenty‐four of the 45 genes found between Cj1293 and Cj1337 in NCTC 11168 are missing in 81–176. Mutation of six new genes, in addition to three previously reported, resulted in a non‐motile phenotype, consistent with a role in synthesis of pseudaminic acid (PseAc) or transfer of PseAc to flagellin. Mutation of Cj1316c or pseA had been shown to result in loss of the acetamidino form of pseudaminic acid (PseAm). Mutation of a second gene also resulted in loss of PseAm, as well as a minor modification that appears to be PseAm extended with N‐acetyl‐glutamic acid. Previously described mutants in C. jejuni 81–176 and Campylobacter coli VC167 that produced flagella lacking PseAm or PseAc failed to autoagglutinate. This suggests that interactions between modifications on adjacent flagella filaments are required for autoagglutination. Mutants (81–176) defective in autoagglutination showed a modest reduction in adherence and invasion of INT407 cells. However, there was a qualitative difference in binding patterns to INT407 cells using GFP‐labelled 81–176 and mutants lacking PseAm. A mutant lacking PseAm was attenuated in the ferret diarrhoeal disease model.